MetaCap

Avalo Therapeutics Insider Trades

NASDAQ: AVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.65+0.22 (+1.64%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
34 · $7.57M
Shares bought / sold
0 / 380.08K
Net activity
Net selling $7.6 million

Avalo Therapeutics insider activity

Over the last 12 months, Avalo Therapeutics insiders reported 65 transactions on SEC Form 4: 0 open-market purchases and 34 sales. Insiders bought $0 and sold $7.6 million worth of stock, for net insider selling of $7.6 million. The largest seller was Sullivan Christopher Ryan, with $3.5 million in reported sales.

The most recent filing shows Sullivan Christopher Ryan (Chief Financial Officer) reporting a transaction in 12,394 shares at $9.88 on Sep 16, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AVTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AVTX insider transactions

Avalo Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 16, 2026Sullivan Christopher RyanChief Financial OfficerSale12,394$202.44KForm 4
Sep 16, 2026Sullivan Christopher RyanChief Financial OfficerOption exercise12,394$122.45KForm 4
Sep 10, 2026Sullivan Christopher RyanChief Financial OfficerSale10,185$179.46KForm 4
Sep 10, 2026Sullivan Christopher RyanChief Financial OfficerOption exercise10,185$81.89KForm 4
Aug 28, 2026Doyle MittieChief Medical OfficerSale679$13.58KForm 4
Aug 28, 2026Doyle MittieChief Medical OfficerOption exercise679$5.46KForm 4
Aug 18, 2026Sullivan Christopher RyanChief Financial OfficerSale31,031$622.32KForm 4
Aug 18, 2026Sullivan Christopher RyanChief Financial OfficerOption exercise31,031$306.59KForm 4
Aug 17, 2026Doyle MittieChief Medical OfficerSale1,000$20.00KForm 4
Aug 17, 2026Doyle MittieChief Medical OfficerOption exercise1,000$12.65KForm 4
Aug 17, 2026Sullivan Christopher RyanChief Financial OfficerSale3,749$74.76KForm 4
Aug 17, 2026Sullivan Christopher RyanChief Financial OfficerSale37,945$753.33KForm 4
Aug 17, 2026Sullivan Christopher RyanChief Financial OfficerOption exercise2,876$28.41KForm 4
Aug 17, 2026Sullivan Christopher RyanChief Financial OfficerOption exercise37,945$374.90KForm 4
Aug 11, 2026Riley JenniferChief Strategy OfficerSale2,655$52.01KForm 4
Aug 10, 2026Doyle MittieChief Medical OfficerSale679$13.58KForm 4
Aug 10, 2026Doyle MittieChief Medical OfficerOption exercise679$5.46KForm 4
Jul 27, 2026Doyle MittieChief Medical OfficerSale1,000$20.00KForm 4
Jul 27, 2026Doyle MittieChief Medical OfficerOption exercise1,000$12.65KForm 4
Jun 30, 2026Doyle MittieChief Medical OfficerSale4,654$93.08KForm 4
Jun 30, 2026Doyle MittieChief Medical OfficerOption exercise1,779$14.30KForm 4
Jun 30, 2026Doyle MittieChief Medical OfficerOption exercise2,875$36.37KForm 4
Jun 23, 2026Doyle MittieChief Medical OfficerSale1,450$26.10KForm 4
Jun 23, 2026Doyle MittieChief Medical OfficerOption exercise1,450$11.66KForm 4
Jun 10, 2026Doyle MittieChief Medical OfficerTax withholding1,084$14.20KForm 4
Jun 10, 2026VARKI PAULChief Legal OfficerTax withholding1,081$14.16KForm 4
Jun 10, 2026Sullivan Christopher RyanChief Financial OfficerTax withholding138$1.81KForm 4
Jun 10, 2026Riley JenniferChief Strategy OfficerTax withholding588$7.70KForm 4
May 28, 2026Doyle MittieChief Medical OfficerSale679$10.86KForm 4
May 28, 2026Doyle MittieChief Medical OfficerOption exercise679$5.46KForm 4
May 21, 2026VARKI PAULChief Legal OfficerAward24,300—Form 4
May 21, 2026Doyle MittieChief Medical OfficerAward43,500—Form 4
May 21, 2026NEIL GARRY ARTHURChief Executive OfficerAward100,200—Form 4
May 21, 2026Sullivan Christopher RyanChief Financial OfficerAward39,900—Form 4
May 21, 2026Riley JenniferChief Strategy OfficerAward34,200—Form 4
May 15, 2026Doyle MittieChief Medical OfficerSale3,000$56.28KForm 4
May 15, 2026Doyle MittieChief Medical OfficerOption exercise3,000$37.95KForm 4
May 7, 2026Sullivan Christopher RyanChief Financial OfficerSale18,606$448.82KForm 4
May 7, 2026Sullivan Christopher RyanChief Financial OfficerOption exercise18,606$183.83KForm 4
May 6, 2026Chan MitchellDirectorSale3,167$72.46KForm 4
May 6, 2026VARKI PAULChief Legal OfficerSale400$9.48KForm 4
May 6, 2026VARKI PAULChief Legal OfficerSale9,253$210.03KForm 4
May 6, 2026VARKI PAULChief Legal OfficerSale22,839$484.54KForm 4
May 6, 2026VARKI PAULChief Legal OfficerSale5,196$102.78KForm 4
May 6, 2026VARKI PAULChief Legal OfficerSale37,375$706.84KForm 4
May 6, 2026VARKI PAULChief Legal OfficerOption exercise12,563$101.01KForm 4
May 6, 2026VARKI PAULChief Legal OfficerOption exercise62,500$839.38KForm 4
May 6, 2026Sullivan Christopher RyanChief Financial OfficerSale8,900$200.91KForm 4
May 6, 2026Sullivan Christopher RyanChief Financial OfficerSale9,219$197.01KForm 4
May 6, 2026Sullivan Christopher RyanChief Financial OfficerSale2,700$56.05KForm 4
May 6, 2026Sullivan Christopher RyanChief Financial OfficerSale12,347$238.09KForm 4
May 6, 2026Sullivan Christopher RyanChief Financial OfficerSale13,834$256.66KForm 4
May 6, 2026Sullivan Christopher RyanChief Financial OfficerOption exercise47,000$377.88KForm 4
May 6, 2026Doyle MittieChief Medical OfficerSale10,058$230.13KForm 4
May 6, 2026Doyle MittieChief Medical OfficerSale19,015$426.05KForm 4
May 6, 2026Doyle MittieChief Medical OfficerSale44,944$952.67KForm 4
May 6, 2026Doyle MittieChief Medical OfficerSale5,000$98.25KForm 4
May 6, 2026Doyle MittieChief Medical OfficerSale27,538$496.41KForm 4
May 6, 2026Doyle MittieChief Medical OfficerOption exercise28,650$230.35KForm 4
May 6, 2026Doyle MittieChief Medical OfficerOption exercise77,905$985.50KForm 4
May 5, 2026Doyle MittieChief Medical OfficerSale1,679$26.86KForm 4
May 5, 2026Doyle MittieChief Medical OfficerOption exercise679$5.46KForm 4
May 5, 2026Doyle MittieChief Medical OfficerOption exercise1,000$12.65KForm 4
Apr 30, 2026Sullivan Christopher RyanChief Financial OfficerSale8,457$111.85KForm 4
Apr 29, 2026Sullivan Christopher RyanChief Financial OfficerSale8,458$110.74KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related